We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Interleukins Produced in Response to Infection by Parasitic Worms Protect the Body from Autoimmune Attack

By LabMedica International staff writers
Posted on 08 Aug 2012
A recent paper discussed the molecular basis for the lower incidence of type I diabetes in developing countries caused by intestinal worm infections.

Chronic intestinal worm infections are known to blunt the effect of the self-aggressive T-cells that cause diabetes and other autoimmune diseases. More...
To determine which molecular signals trigger this loss of autoimmune activity investigators at the University of Medicine and Dentistry of New Jersey (Newark, USA) infected nonobese diabetic (NOD) mice with the strictly enteric nematode parasite, Heligmosomoides polygyrus and then evaluated the types of cytokines produced by these animals.

They reported in the July 18, 2012, online edition of the journal Mucosal Immunology that two weeks of infection with H. polygyrus (which was then cured using oral drugs) induced T-cells to produce the cytokines interleukin (IL)-4 and IL-10, which acted independently to block T-cell autoimmune activity and provide lasting protection against development of type I diabetes. Blockade of IL-10 signaling in some mice during this short interval eliminated the protective effects of the worm infection and resulted in pancreatic beta-cell destruction and ultimately type I diabetes.

These results outline potential mechanisms to explain the potency of parasite-induced control of inflammatory diseases. Follow-up clinical studies are using eggs from another parasitic worm, Trichuris suis, to treat patients with Crohn’s disease and multiple sclerosis.

Related Links:
University of Medicine and Dentistry of New Jersey




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.